Table:
begin	end	state
1	29	non-cytoplasmic
30	48	transmembrane
49	59	cytoplasmic
60	88	transmembrane
89	106	non-cytoplasmic
107	127	transmembrane
128	196	cytoplasmic
197	220	transmembrane
221	239	non-cytoplasmic
240	259	transmembrane
260	292	cytoplasmic
293	311	transmembrane
312	316	non-cytoplasmic
317	335	transmembrane
336	346	cytoplasmic
347	369	transmembrane
370	380	non-cytoplasmic
381	400	transmembrane
401	407	cytoplasmic
408	452	transmembrane
453	457	non-cytoplasmic
458	464	cytoplasmic
465	487	transmembrane
488	493	non-cytoplasmic

Input:
>WP_042446385.1 NCBI__GCF_002893965.1:WP_042446385.1
MSEAKSESTESFSETTPPAEPSKQSVLRRYYPAAVPVVLGLIIYFMPVPDGVDPKGMHML
GIFVGTIVALILQPLPTGSVALVGLSIAMITQTETPTEALSGFSNTTIWLIVASFFIAEG
FLVTGLGKRVALMFVTKLGKSSLGLSYGMALTDLILAPATPSNTARAGGVVYPIIVSLSK
LEDSNPEPEDSRKKLGAYLLLTSLQVNVVTSAMFITAMAGNPVAVDAAAKIGIDISWGKW
ALAASVPGIASLIAIPWVMSKIFPPTMLKTPKAPEQAREELRKAGPISRNEKIMAATFVL
LLVLWCLGSQLNVNATTTAFVGIGILLVTKVLTWNNLVHDTGAWQTLVFFAVLVGMASHL
EELGVISWIGTQVSSSVDGLPWIWAFAILTLVYFYAHYLFASNTAQIVAMYAVFLGAAVA
TGAPPLFSALVFGFIGSLFGGISHYASGPAGVIYGSGYIKTSEWFRIGFVMSVVIILIWT
IIGGAWMKLIGAW

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server